Browsing by Author Xuereb, Robert G.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 37  next >
Issue DateTitleAuthor(s)
2014Antiplatelet and anticoagulant therapy for non-ST-elevation acute coronary syndromes in a general hospitalMason, Giorgia; Wirth, Francesca; Cignarella, Andrea; Xuereb, Robert G.; Azzopardi, Lilian M.
2013-10Antiplatelet and anticoagulation treatment for non-ST-elevation acute coronary syndromesMason, Giorgia; Wirth, Francesca; Azzopardi, Lilian M.; Xuereb, Robert G.; Cignarella, Andrea
2019-03Assessing medication adherence and condition-related knowledge of heart failure patientsDebono, Ivan; Grech, Louise; Xuereb, Robert G.; Azzopardi, Lilian M.
2015-06Association of the CYP2C19 *2 allele on the occurrence of in-stent restenosis in patients undergoing coronary stentingWirth, Francesca; Zahra, Graziella; Xuereb, Robert G.; Barbara, Christopher; Fenech, Albert; Azzopardi, Lilian M.
2010Atrial fibrillation : a common arrhythmia with possible dire consequencesXuereb, Robert G.
2019-09Cardiac rehabilitation and smoking statusAnders, Henry O.; Wirth, Francesca; Gauci, Marilyn; Xuereb, Clifford; Desira, Josette; Xuereb, Robert G.; Azzopardi, Lilian M.
2020Comparative analysis of lipid profile management in ischaemic heart diseaseZarb, Maia; Xuereb, Robert G.; Wirth, Francesca; Azzopardi, Lilian M.
2015-10Comparison between a point-of-care and a laboratory-based CYP2C19*2 genotyping assay for pharmacist-led personalisation of antiplatelet therapyWirth, Francesca; Zahra, Graziella; Xuereb, Robert G.; Barbara, Christopher; Fenech, Albert; Azzopardi, Lilian M.
2016Comparison of a rapid point-of-care and two laboratory-based CYP2C19*2 genotyping assays for personalisation of antiplatelet therapyWirth, Francesca; Zahra, Graziella; Xuereb, Robert G.; Barbara, Christopher; Fenech, Albert; Azzopardi, Lilian M.
1992Coronary artery spasm : role in acute myocardial ischaemiaXuereb, Robert G.; Xuereb, Mariosa
2019-02CYP2C19 genetic polymorphisms in Maltese patients on clopidogrel therapyWirth, Francesca; Zahra, Graziella; Xuereb, Robert G.; Barbara, Christopher; Camilleri, Liberato; Fenech, Albert; Azzopardi, Lilian M.
2021CYP2C19* 2 genetic polymorphism and incidence of in-stent restenosis in patients on clopidogrel : a matched case-control studyOsama, Sara; Wirth, Francesca; Zahra, Graziella; Barbara, Christopher; Xuereb, Robert G.; Camilleri, Liberato; Azzopardi, Lilian M.
2018CYP2C19*2 allele carrier status and coronary in-stent restenosis : is there an association?Wirth, Francesca; Zahra, Graziella; Xuereb, Robert G.; Barbara, Christopher; Camilleri, Liberato; Fenech, Albert; Azzopardi, Lilian M.
2020CYP2C19*2 genetic polymorphism and other predictors for coronary in-stent restenosis in patients on clopidogrel therapyOsama, Sara; Wirth, Francesca; Zahra, Graziella; Xuereb, Robert G.; Azzopardi, Lilian M.
2020Evaluating the safety and tolerability of sacubitril/valsartanVandenbroeke, Helena; Wirth, Francesca; Xuereb, Robert G.; Steurbaut, Stephane; Azzopardi, Lilian M.
2023-04Experience with statin therapy in patients undergoing cardiac proceduresCalleja, Jean Claude; Wirth, Francesca; Xuereb, Robert G.; Azzopardi, Lilian M.
2016Female gender and cardiovascular diseaseXuereb, Rachel; Magri, Caroline J.; Xuereb, Sara; Xuereb, Mariosa; Zammit-Mangion, Marion; Xuereb, Robert G.
2017-10Impact of rivaroxaban in cardiovascular diseaseCardona, Mark; Wirth, Francesca; Serracino-Inglott, Anthony; Xuereb, Robert G.; Azzopardi, Lilian M.
2003The long and winding road: the management of Acute Coronary Syndromes in MaltaXuereb, Robert G.; Xuereb, Mariosa
2018-10Low density lipoprotein control in patients with ischaemic heart diseaseCurtolo, Elisa; Wirth, Francesca; Xuereb, Robert G.; Camilleri, Liberato; Cignarella, Andrea; Azzopardi, Lilian M.